✦ LIBER ✦

Lack of efficacy of low-dose subcutaneous recombinant interleukin-2 and interferon-a in the treatment of metastatic renal cell carcinoma

✍ Scribed by N. Thiounn; C. Mathiot; T. Dorval; T.A. Flam; E. Tartour; V. Mosseri; M. Zerbib; W.H. Fridman; B. Debre

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subcutaneous low-dose recombinant interl

✍ Gaston, R; Oskam, R; Philip, T; Ravaud, A; Négrier, S; Cany, L; Merrouche, Y; Le 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 876 KB

A combination of subcutaneous recombinan

✍ Vuoristo, Merisisko; Jantunen, Ismo; Pyrhönen, Seppo; Muhonen, Timo; Kellokumpu- 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 410 KB

A phase II study of interferon α and low

✍ A. Piga; Paolo Giordani; Agata Quattrone; Marco Giulioni; Giorgio De Signoribus; 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 72 KB

Recombinant interleukin-2 (RIL-2) + inte

✍ Santoro, A.; Maiorino, L.; Santoro, M. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Low-dose regimen of interleukin-2 for me

✍ Sleijfer, D.Th.; Janssen, R.A.J.; Willemse, P.H.B.; Martens, A.; De Leij, L.; De 📂 Article 📅 1990 🏛 The Lancet 🌐 English ⚖ 351 KB

Combination of interleukin-2 and gamma i

✍ Escudier, B.; Antoun, S.; Leclercq, B.; Nitenberg, G.; Farace, F.; Angevin, E.; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 470 KB